Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Apr 28, 2026
Coherent Corp. (COHR): +32% Surge in 30 Days Amid AI Optics Demand

Coherent Corp. (COHR): +32% Surge in 30 Days Amid AI Optics Demand

Key Takeaways

  • Coherent Corp. (COHR) stock surged +32% over the past 30 days amid strong AI-driven demand for optical networking components.
  • Over the past quarter, shares climbed +45%, fueled by S&P 500 inclusion and robust earnings performance.
  • Key drivers include photonic sector momentum, upward earnings revisions, and growth in datacom applications.
  • Recent volatility reflects profit-taking after new highs, but the uptrend remains intact.
  • Upcoming Q3 fiscal 2026 earnings on May 6 could provide further catalysts.

Coherent Corp. (COHR): Company Overview and Market Position

Coherent Corp. stands out as a leading provider of engineered materials, optoelectronic components, and laser systems, serving industrial, communications, electronics, and instrumentation markets worldwide. The company operates through three main segments: Networking, which supplies transceivers and optics for datacenters and telecom; Materials, offering advanced ceramics and semiconductors; and Lasers, delivering systems for manufacturing and research. Formerly II-VI Incorporated, COHR rebranded in 2022 after acquiring Coherent Inc. From what I see, its positioning in high-growth areas like AI datacom and photonics has been a key factor in the recent stock strength, as demand for high-speed optical transceivers picks up pace.

COHR Stock Performance: Last 30 Days vs. Quarter

In the last 30 days, COHR stock rose +32%, moving from a close of about $243 on March 27 to $322 on April 27. The path was volatile yet trend-driven, with shares dipping to $220 early on before rallying to a peak near $365 mid-April, then pulling back amid broader market profit-taking. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the underlying momentum.

Over the past quarter, the stock gained +45%, advancing from around $221 on January 28 to $322. It featured sharp swings, including a post-earnings dip in early February and a strong March rebound, with high volume on upward days and a bullish trajectory tied to sector tailwinds.

What Drove COHR Stock +32% in the Last 30 Days

The +32% gain in COHR reflected sustained momentum in the photonics and optics sector, driven by AI demand for datacenter transceivers and networking gear. Photonic stocks like COHR jumped in mid-March on news of an impending "optics supercycle," lifting investor sentiment. The stock benefited from its March S&P 500 inclusion with other AI-linked names, drawing more visibility and institutional buying. Analyst EPS estimates rose over the period, with no downgrades. Short-term volatility came from profit-taking after April highs, but positive revisions for upcoming quarters and AI datacom exposure kept the uptrend alive.

What Powered COHR Stock's +45% Quarterly Gain

COHR's +45% quarterly advance was anchored by February's Q2 fiscal 2026 earnings beat, with revenue of $1.69 billion exceeding forecasts by 17-22% year-over-year on a pro forma basis, thanks to AI datacenter and telecom growth. Despite an initial 12% post-earnings drop on inline Q3 guidance, shares recovered sharply. The March S&P 500 addition, linked to Nvidia-adjacent AI optics plays, ignited a rally, amplified by photonic demand news. Broader tailwinds like resilient tech spending amid moderating rates supported the gains, with institutional accumulation clear in trading volumes. One thing that stands out to me is how these factors aligned so well.

Trending AI Robots

I regularly turn to Tickeron’s Trending AI Robots page to spot top-performing AI trading bots from hundreds available. These bots analyze thousands of tickers across strategies, timeframes, and metrics like win rate, profit factor, and drawdown, highlighting those thriving in current conditions—perfect for opportunities in stocks like COHR. Whether it's momentum, mean reversion, or sector trends, the dynamic selection helps me integrate data-driven automation into my approach. Check out Trending AI Robots if you're looking to do the same.

COHR Outlook: What I'm Watching Next

I'm keeping a close eye on Q3 fiscal 2026 earnings on May 6 for insights into datacom revenue and AI guidance. Continued photonic demand, telecom capex, and silicon carbide progress will be crucial. Macro factors like interest rates and tech rotation could sway sentiment, while partnerships, supply chain resilience, and optics competition deserve attention. Risks around execution and market volatility remain, but in my view, the setup looks promising if trends hold.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: COHR

COHR in upward trend: 10-day moving average crossed above 50-day moving average on September 28, 2026

The 10-day moving average for COHR crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on COHR as a result. In 66 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for COHR just turned positive on October 01, 2026. Looking at past instances where COHR's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.

COHR moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +17.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where COHR advanced for three days, in 290 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

COHR broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COHR entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. COHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.074) is normal, around the industry mean (4.255). P/E Ratio (68.556) is within average values for comparable stocks, (88.653). Projected Growth (PEG Ratio) (2.330) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (7.955) is also within normal values, averaging (32.028).

The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 9.16B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -2%. SOTK experienced the highest price growth at 34%, while SVRE experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 57
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 80
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
COHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of laser diodes and other laser equipment

Industry ElectronicEquipmentInstruments

Industry
Electronic Equipment Or Instruments
Address
375 Saxonburg Boulevard
Phone
+1 724 352-4455
Employees
51478
Web
https://www.coherent.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.